Company Overview
ARMATA PHARMACEUTICALS, INC.
ARMPRevenue vs. Cost of Revenue
Revenue
Cost of Revenue
Total Operating Expenses vs. Operating Income
Total Operating Expenses
Operating Income
Net Income
Net Income
Revenue
—M
2025 FY
Net Income
-174M
2025 FY
Shares Outstanding
36M
2025 FY
EPS
-4.8USD
2025 FY
Company Information
SIC Code
2836
CIK Code
921114
Exchange
NYSE
Location
US